World Stroke Day Observed at SRHU with Expert Talk on Stroke Burden in India

Published on: October 29, 2025

World Stroke Day Observed at SRHU with Expert Talk on Stroke Burden in India

October 29 is recognised worldwide as World Stroke Day, aiming to raise awareness about stroke, its warning signs, prevention methods, and the need for prompt medical treatment. To mark this day, Dr Kanchan Bisht and Dr Kaushik Pramod Sharma, both Associate Professors and Scientists at the Department of Neurology, Himalayan Institute of Medical Sciences (HIMS), SRHU, organised an awareness session highlighting the increasing impact of stroke in India. The event underscored the shared responsibility of healthcare providers and the community in achieving better outcomes for stroke patients.

The invited talk, titled “Stroke Burden in India,” was delivered by Dr Deepak Goel, Professor and Head of the Department of Neurology at HIMS. He is a highly respected neurologist whose compassionate patient care and long-standing commitment to stroke prevention and treatment have made him a leading voice in advancing stroke awareness and improving neurological health in Uttarakhand. Addressing an audience that included clinicians, residents, nursing and emergency care teams, as well as allied health professionals involved in patient care, Dr Goel highlighted the numerous challenges associated with stroke prevention, management, and rehabilitation in India.

According to the WHO 2024 data, stroke is the second leading cause of death globally. India sees over 1.4 million new cases each year, with patients averaging 9.5 hours to reach a hospital, and up to 18 hours in Uttarakhand, often travelling over 100 kilometres for treatment, risking critical time to save the brain. Dr Goel pointed out that only two per cent of Indian patients receive life-saving therapy in time, a statistic that can and must change through greater public awareness and rapid response. He also noted that Uttarakhand currently lacks a comprehensive stroke care centre, and that HIMS, SRHU is actively working to establish one so that patients can receive the timely, advanced treatment they deserve and the state’s growing stroke burden can be effectively addressed.

He stressed that stroke is not only a disease of the brain but a crisis for the entire family. Survivors often face long-term disability, dependence, and emotional distress, while caregivers struggle with financial and mental strain. Early recognition of stroke warning signs, such as sudden weakness, slurred speech, or facial drooping, can save lives if acted upon immediately. Dr Goel emphasised that controlling blood pressure and diabetes, avoiding tobacco and alcohol, regular exercise, and timely follow-up after treatment are the strongest defences against stroke. He concluded that stroke prevention is not just a duty of doctors or hospitals, but a shared responsibility of every individual and community, because every minute saved means a life and a family preserved. A simple take-home reminder for everyone is the acronym FASTFace drooping, Arm weakness, Speech difficulty, and Time to call for help, which can make the difference between recovery and lifelong disability. As emphasised throughout the session, in stroke care, “Time is Brain” and every minute saved can make the difference between recovery and lifelong disability.

Screenshot 2025-10-29 132002
Screenshot 2025-10-29 131821
Screenshot 2025-10-29 131852
Screenshot 2025-10-29 131904
Screenshot 2025-10-29 131917
Screenshot 2025-10-29 131930
Screenshot 2025-10-29 131949
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.